Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
- DOI
- 10.1093/neuonc/nox208
- Published
- 2017-10-28
- Container
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/neuonc/nox208,
title = {Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143},
author = {Antonio Omuro and Gordana Vlahovic and Michael Lim and Solmaz Sahebjam and Joachim Baehring and Timothy Cloughesy and Alfredo Voloschin and Shakti H Ramkissoon and Keith L Ligon and Robert Latek and Ricardo Zwirtes and Lewis Strauss and Prashni Paliwal and Christopher T Harbison and David A Reardon and John H Sampson},
year = {2017},
journal = {Neuro-Oncology},
doi = {10.1093/neuonc/nox208},
url = {https://doi.org/10.1093/neuonc/nox208}
}RIS
TY - JOUR TI - Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143 AU - Antonio Omuro AU - Gordana Vlahovic AU - Michael Lim AU - Solmaz Sahebjam AU - Joachim Baehring AU - Timothy Cloughesy AU - Alfredo Voloschin AU - Shakti H Ramkissoon AU - Keith L Ligon AU - Robert Latek AU - Ricardo Zwirtes AU - Lewis Strauss AU - Prashni Paliwal AU - Christopher T Harbison AU - David A Reardon AU - John H Sampson PY - 2017 JO - Neuro-Oncology DO - 10.1093/neuonc/nox208 UR - https://doi.org/10.1093/neuonc/nox208 ER -
APA
Omuro, A., Vlahovic, G., Lim, M., Sahebjam, S., Baehring, J., Cloughesy, T., Voloschin, A., Ramkissoon, S. H., Ligon, K. L., Latek, R., Zwirtes, R., Strauss, L., Paliwal, P., Harbison, C. T., Reardon, D. A., & Sampson, J. H. (2017). Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143. Neuro-Oncology. https://doi.org/10.1093/neuonc/nox208
Source records
- crossref · retrieved 2026-09-27T12:48:06.729Z